aluates Reports

$ 0.0

Automative

Poliovirus Vaccine Inactivated - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-25O12089

Global Poliovirus Vaccine Inactivated Industry Research Report Growth Trends and Competitive Analysis 2022 2028

BUY CHAPTERS

Poliovirus Vaccine Inactivated - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-25O12089

Report

September 2024

Pages:82

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi

GSK

Serum Institute (Bilthoven Biologicals)

IMBCA

Poliovirus Vaccine Inactivated - Market Size

The global market for Poliovirus Vaccine Inactivated was estimated to be worth US$ 688.5 million in 2023 and is forecast to a readjusted size of US$ 926.8 million by 2030 with a CAGR of 4.4% during the forecast period 2024-2030

Poliovirus Vaccine Inactivated - Market

Inactivated polio vaccine (IPV) IPV is produced from wild-type poliovirus strains of each serotype that have been inactivated (killed) with formalin.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Poliovirus Vaccine Inactivated, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Poliovirus Vaccine Inactivated by region & country, by Type, and by Application.

The Poliovirus Vaccine Inactivated market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Poliovirus Vaccine Inactivated.

Market Segmentation

Scope of Poliovirus Vaccine Inactivated - Market Report

Report Metric	Details
Report Name	Poliovirus Vaccine Inactivated - Market
Forecasted market size in 2030	US$ 926.8 million
CAGR	4.4%
Forecasted years	2024 - 2030
Segment by Type:	Human Diploid Cell Monkey Kidney Cell
Segment by Application	Public Private
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, GSK, Serum Institute (Bilthoven Biologicals), IMBCA
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Poliovirus Vaccine Inactivated manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Poliovirus Vaccine Inactivated in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Poliovirus Vaccine Inactivated in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Poliovirus Vaccine Inactivated - Market size in 2030?

Ans: The Poliovirus Vaccine Inactivated - Market size in 2030 will be US$ 926.8 million.

Who are the main players in the Poliovirus Vaccine Inactivated - Market report?

Ans: The main players in the Poliovirus Vaccine Inactivated - Market are Sanofi, GSK, Serum Institute (Bilthoven Biologicals), IMBCA

What are the Application segmentation covered in the Poliovirus Vaccine Inactivated - Market report?

Ans: The Applications covered in the Poliovirus Vaccine Inactivated - Market report are Public, Private

What are the Type segmentation covered in the Poliovirus Vaccine Inactivated - Market report?

Ans: The Types covered in the Poliovirus Vaccine Inactivated - Market report are Human Diploid Cell, Monkey Kidney Cell

Recommended Reports

Polio and Other Vaccines

Vaccine Technology & Adjuvants

Vaccine Logistics & Packaging

1 Market Overview

1.1 Poliovirus Vaccine Inactivated Product Introduction

1.2 Global Poliovirus Vaccine Inactivated Market Size Forecast

1.2.1 Global Poliovirus Vaccine Inactivated Sales Value (2019-2030)

1.2.2 Global Poliovirus Vaccine Inactivated Sales Volume (2019-2030)

1.2.3 Global Poliovirus Vaccine Inactivated Sales Price (2019-2030)

1.3 Poliovirus Vaccine Inactivated Market Trends & Drivers

1.3.1 Poliovirus Vaccine Inactivated Industry Trends

1.3.2 Poliovirus Vaccine Inactivated Market Drivers & Opportunity

1.3.3 Poliovirus Vaccine Inactivated Market Challenges

1.3.4 Poliovirus Vaccine Inactivated Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Poliovirus Vaccine Inactivated Players Revenue Ranking (2023)

2.2 Global Poliovirus Vaccine Inactivated Revenue by Company (2019-2024)

2.3 Global Poliovirus Vaccine Inactivated Players Sales Volume Ranking (2023)

2.4 Global Poliovirus Vaccine Inactivated Sales Volume by Company Players (2019-2024)

2.5 Global Poliovirus Vaccine Inactivated Average Price by Company (2019-2024)

2.6 Key Manufacturers Poliovirus Vaccine Inactivated Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Poliovirus Vaccine Inactivated Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Poliovirus Vaccine Inactivated

2.9 Poliovirus Vaccine Inactivated Market Competitive Analysis

2.9.1 Poliovirus Vaccine Inactivated Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Poliovirus Vaccine Inactivated Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poliovirus Vaccine Inactivated as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Human Diploid Cell

3.1.2 Monkey Kidney Cell

3.2 Global Poliovirus Vaccine Inactivated Sales Value by Type

3.2.1 Global Poliovirus Vaccine Inactivated Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Poliovirus Vaccine Inactivated Sales Value, by Type (2019-2030)

3.2.3 Global Poliovirus Vaccine Inactivated Sales Value, by Type (%) (2019-2030)

3.3 Global Poliovirus Vaccine Inactivated Sales Volume by Type

3.3.1 Global Poliovirus Vaccine Inactivated Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Poliovirus Vaccine Inactivated Sales Volume, by Type (2019-2030)

3.3.3 Global Poliovirus Vaccine Inactivated Sales Volume, by Type (%) (2019-2030)

3.4 Global Poliovirus Vaccine Inactivated Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Public

4.1.2 Private

4.2 Global Poliovirus Vaccine Inactivated Sales Value by Application

4.2.1 Global Poliovirus Vaccine Inactivated Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Poliovirus Vaccine Inactivated Sales Value, by Application (2019-2030)

4.2.3 Global Poliovirus Vaccine Inactivated Sales Value, by Application (%) (2019-2030)

4.3 Global Poliovirus Vaccine Inactivated Sales Volume by Application

4.3.1 Global Poliovirus Vaccine Inactivated Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Poliovirus Vaccine Inactivated Sales Volume, by Application (2019-2030)

4.3.3 Global Poliovirus Vaccine Inactivated Sales Volume, by Application (%) (2019-2030)

4.4 Global Poliovirus Vaccine Inactivated Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Poliovirus Vaccine Inactivated Sales Value by Region

5.1.1 Global Poliovirus Vaccine Inactivated Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Poliovirus Vaccine Inactivated Sales Value by Region (2019-2024)

5.1.3 Global Poliovirus Vaccine Inactivated Sales Value by Region (2025-2030)

5.1.4 Global Poliovirus Vaccine Inactivated Sales Value by Region (%), (2019-2030)

5.2 Global Poliovirus Vaccine Inactivated Sales Volume by Region

5.2.1 Global Poliovirus Vaccine Inactivated Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Poliovirus Vaccine Inactivated Sales Volume by Region (2019-2024)

5.2.3 Global Poliovirus Vaccine Inactivated Sales Volume by Region (2025-2030)

5.2.4 Global Poliovirus Vaccine Inactivated Sales Volume by Region (%), (2019-2030)

5.3 Global Poliovirus Vaccine Inactivated Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Poliovirus Vaccine Inactivated Sales Value, 2019-2030

5.4.2 North America Poliovirus Vaccine Inactivated Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Poliovirus Vaccine Inactivated Sales Value, 2019-2030

5.5.2 Europe Poliovirus Vaccine Inactivated Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Poliovirus Vaccine Inactivated Sales Value, 2019-2030

5.6.2 Asia Pacific Poliovirus Vaccine Inactivated Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Poliovirus Vaccine Inactivated Sales Value, 2019-2030

5.7.2 South America Poliovirus Vaccine Inactivated Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Poliovirus Vaccine Inactivated Sales Value, 2019-2030

5.8.2 Middle East & Africa Poliovirus Vaccine Inactivated Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Poliovirus Vaccine Inactivated Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Poliovirus Vaccine Inactivated Sales Value

6.2.1 Key Countries/Regions Poliovirus Vaccine Inactivated Sales Value, 2019-2030

6.2.2 Key Countries/Regions Poliovirus Vaccine Inactivated Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Poliovirus Vaccine Inactivated Sales Value, 2019-2030

6.3.2 United States Poliovirus Vaccine Inactivated Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Poliovirus Vaccine Inactivated Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Poliovirus Vaccine Inactivated Sales Value, 2019-2030

6.4.2 Europe Poliovirus Vaccine Inactivated Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Poliovirus Vaccine Inactivated Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Poliovirus Vaccine Inactivated Sales Value, 2019-2030

6.5.2 China Poliovirus Vaccine Inactivated Sales Value by Type (%), 2023 VS 2030

6.5.3 China Poliovirus Vaccine Inactivated Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Poliovirus Vaccine Inactivated Sales Value, 2019-2030

6.6.2 Japan Poliovirus Vaccine Inactivated Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Poliovirus Vaccine Inactivated Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Poliovirus Vaccine Inactivated Sales Value, 2019-2030

6.7.2 South Korea Poliovirus Vaccine Inactivated Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Poliovirus Vaccine Inactivated Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Poliovirus Vaccine Inactivated Sales Value, 2019-2030

6.8.2 Southeast Asia Poliovirus Vaccine Inactivated Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Poliovirus Vaccine Inactivated Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Poliovirus Vaccine Inactivated Sales Value, 2019-2030

6.9.2 India Poliovirus Vaccine Inactivated Sales Value by Type (%), 2023 VS 2030

6.9.3 India Poliovirus Vaccine Inactivated Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Sanofi

7.1.1 Sanofi Company Information

7.1.2 Sanofi Introduction and Business Overview

7.1.3 Sanofi Poliovirus Vaccine Inactivated Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Sanofi Poliovirus Vaccine Inactivated Product Offerings

7.1.5 Sanofi Recent Development

7.2 GSK

7.2.1 GSK Company Information

7.2.2 GSK Introduction and Business Overview

7.2.3 GSK Poliovirus Vaccine Inactivated Sales, Revenue and Gross Margin (2019-2024)

7.2.4 GSK Poliovirus Vaccine Inactivated Product Offerings

7.2.5 GSK Recent Development

7.3 Serum Institute (Bilthoven Biologicals)

7.3.1 Serum Institute (Bilthoven Biologicals) Company Information

7.3.2 Serum Institute (Bilthoven Biologicals) Introduction and Business Overview

7.3.3 Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Product Offerings

7.3.5 Serum Institute (Bilthoven Biologicals) Recent Development

7.4 IMBCA

7.4.1 IMBCA Company Information

7.4.2 IMBCA Introduction and Business Overview

7.4.3 IMBCA Poliovirus Vaccine Inactivated Sales, Revenue and Gross Margin (2019-2024)

7.4.4 IMBCA Poliovirus Vaccine Inactivated Product Offerings

7.4.5 IMBCA Recent Development

8 Industry Chain Analysis

8.1 Poliovirus Vaccine Inactivated Industrial Chain

8.2 Poliovirus Vaccine Inactivated Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Poliovirus Vaccine Inactivated Sales Model

8.5.2 Sales Channel

8.5.3 Poliovirus Vaccine Inactivated Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Sanofi

GSK

Serum Institute (Bilthoven Biologicals)

IMBCA

List of Tables

Table 1. Poliovirus Vaccine Inactivated Market Trends

Table 2. Poliovirus Vaccine Inactivated Market Drivers & Opportunity

Table 3. Poliovirus Vaccine Inactivated Market Challenges

Table 4. Poliovirus Vaccine Inactivated Market Restraints

Table 5. Global Poliovirus Vaccine Inactivated Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Poliovirus Vaccine Inactivated Revenue Market Share by Company (2019-2024)

Table 7. Global Poliovirus Vaccine Inactivated Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Poliovirus Vaccine Inactivated Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Poliovirus Vaccine Inactivated Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Poliovirus Vaccine Inactivated Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Poliovirus Vaccine Inactivated Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Poliovirus Vaccine Inactivated

Table 13. Global Poliovirus Vaccine Inactivated Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poliovirus Vaccine Inactivated as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Poliovirus Vaccine Inactivated Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Poliovirus Vaccine Inactivated Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Poliovirus Vaccine Inactivated Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Poliovirus Vaccine Inactivated Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Poliovirus Vaccine Inactivated Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Poliovirus Vaccine Inactivated Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Poliovirus Vaccine Inactivated Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Poliovirus Vaccine Inactivated Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Poliovirus Vaccine Inactivated Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Poliovirus Vaccine Inactivated Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Poliovirus Vaccine Inactivated Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Poliovirus Vaccine Inactivated Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Poliovirus Vaccine Inactivated Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Poliovirus Vaccine Inactivated Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Poliovirus Vaccine Inactivated Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Poliovirus Vaccine Inactivated Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Poliovirus Vaccine Inactivated Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Poliovirus Vaccine Inactivated Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Poliovirus Vaccine Inactivated Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Poliovirus Vaccine Inactivated Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Poliovirus Vaccine Inactivated Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Poliovirus Vaccine Inactivated Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Poliovirus Vaccine Inactivated Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Poliovirus Vaccine Inactivated Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Poliovirus Vaccine Inactivated Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Poliovirus Vaccine Inactivated Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Poliovirus Vaccine Inactivated Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Poliovirus Vaccine Inactivated Sales Value by Region (2019-2024) & (%)

Table 44. Global Poliovirus Vaccine Inactivated Sales Value by Region (2025-2030) & (%)

Table 45. Global Poliovirus Vaccine Inactivated Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Poliovirus Vaccine Inactivated Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Poliovirus Vaccine Inactivated Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Poliovirus Vaccine Inactivated Sales Volume by Region (2019-2024) & (%)

Table 49. Global Poliovirus Vaccine Inactivated Sales Volume by Region (2025-2030) & (%)

Table 50. Global Poliovirus Vaccine Inactivated Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Poliovirus Vaccine Inactivated Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Poliovirus Vaccine Inactivated Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Poliovirus Vaccine Inactivated Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Poliovirus Vaccine Inactivated Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Poliovirus Vaccine Inactivated Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Poliovirus Vaccine Inactivated Sales Volume, (2025-2030) & (K Units)

Table 57. Sanofi Company Information

Table 58. Sanofi Introduction and Business Overview

Table 59. Sanofi Poliovirus Vaccine Inactivated Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Sanofi Poliovirus Vaccine Inactivated Product Offerings

Table 61. Sanofi Recent Development

Table 62. GSK Company Information

Table 63. GSK Introduction and Business Overview

Table 64. GSK Poliovirus Vaccine Inactivated Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. GSK Poliovirus Vaccine Inactivated Product Offerings

Table 66. GSK Recent Development

Table 67. Serum Institute (Bilthoven Biologicals) Company Information

Table 68. Serum Institute (Bilthoven Biologicals) Introduction and Business Overview

Table 69. Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Product Offerings

Table 71. Serum Institute (Bilthoven Biologicals) Recent Development

Table 72. IMBCA Company Information

Table 73. IMBCA Introduction and Business Overview

Table 74. IMBCA Poliovirus Vaccine Inactivated Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. IMBCA Poliovirus Vaccine Inactivated Product Offerings

Table 76. IMBCA Recent Development

Table 77. Key Raw Materials Lists

Table 78. Raw Materials Key Suppliers Lists

Table 79. Poliovirus Vaccine Inactivated Downstream Customers

Table 80. Poliovirus Vaccine Inactivated Distributors List

Table 81. Research Programs/Design for This Report

Table 82. Key Data Information from Secondary Sources

Table 83. Key Data Information from Primary Sources

List of Figures

Figure 1. Poliovirus Vaccine Inactivated Product Picture

Figure 2. Global Poliovirus Vaccine Inactivated Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Poliovirus Vaccine Inactivated Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Poliovirus Vaccine Inactivated Sales Volume (2019-2030) & (K Units)

Figure 5. Global Poliovirus Vaccine Inactivated Sales Price (2019-2030) & (USD/Unit)

Figure 6. Poliovirus Vaccine Inactivated Report Years Considered

Figure 7. Global Poliovirus Vaccine Inactivated Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Poliovirus Vaccine Inactivated Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Poliovirus Vaccine Inactivated Revenue in 2023

Figure 10. Poliovirus Vaccine Inactivated Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Human Diploid Cell Picture

Figure 12. Monkey Kidney Cell Picture

Figure 13. Global Poliovirus Vaccine Inactivated Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Poliovirus Vaccine Inactivated Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Poliovirus Vaccine Inactivated Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Poliovirus Vaccine Inactivated Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Poliovirus Vaccine Inactivated Price by Type (2019-2030) & (USD/Unit)

Figure 18. Product Picture of Public

Figure 19. Product Picture of Private

Figure 20. Global Poliovirus Vaccine Inactivated Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Poliovirus Vaccine Inactivated Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Poliovirus Vaccine Inactivated Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 23. Global Poliovirus Vaccine Inactivated Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Poliovirus Vaccine Inactivated Price by Application (2019-2030) & (USD/Unit)

Figure 25. North America Poliovirus Vaccine Inactivated Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Poliovirus Vaccine Inactivated Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Poliovirus Vaccine Inactivated Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Poliovirus Vaccine Inactivated Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Poliovirus Vaccine Inactivated Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Poliovirus Vaccine Inactivated Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Poliovirus Vaccine Inactivated Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Poliovirus Vaccine Inactivated Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Poliovirus Vaccine Inactivated Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Poliovirus Vaccine Inactivated Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Poliovirus Vaccine Inactivated Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Poliovirus Vaccine Inactivated Sales Volume (%), (2019-2030)

Figure 37. United States Poliovirus Vaccine Inactivated Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Poliovirus Vaccine Inactivated Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Poliovirus Vaccine Inactivated Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Poliovirus Vaccine Inactivated Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Poliovirus Vaccine Inactivated Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Poliovirus Vaccine Inactivated Sales Value by Application (%), 2023 VS 2030

Figure 43. China Poliovirus Vaccine Inactivated Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Poliovirus Vaccine Inactivated Sales Value by Type (%), 2023 VS 2030

Figure 45. China Poliovirus Vaccine Inactivated Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Poliovirus Vaccine Inactivated Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Poliovirus Vaccine Inactivated Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Poliovirus Vaccine Inactivated Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Poliovirus Vaccine Inactivated Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Poliovirus Vaccine Inactivated Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Poliovirus Vaccine Inactivated Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Poliovirus Vaccine Inactivated Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Poliovirus Vaccine Inactivated Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Poliovirus Vaccine Inactivated Sales Value by Application (%), 2023 VS 2030

Figure 55. India Poliovirus Vaccine Inactivated Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Poliovirus Vaccine Inactivated Sales Value by Type (%), 2023 VS 2030

Figure 57. India Poliovirus Vaccine Inactivated Sales Value by Application (%), 2023 VS 2030

Figure 58. Poliovirus Vaccine Inactivated Industrial Chain

Figure 59. Poliovirus Vaccine Inactivated Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Inactivated Polio Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Inactivated Polio and Rabies Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Polio Vaccination Market Research Report 2025

Global Poliomyelitis Vaccine Market Research Report 2025

Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Combined Polio Vaccine Market Research Report 2024

Inactivated Vaccine Market

Polio Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pet Inactivated Vaccine Market Research Report 2025

Global Poliomycetes Vaccine Market Insights Forecast to 2030

Inactivated Vaccine for Swine Mycoplasma Pneumonia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Inactivated Polio Virus Vaccine Market Research Report 2025

Global Sabin Inactivated Polio vaccine sIPV Market Research Report 2025

Porcine Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Swine Hyopneumoniae Mycoplasma Inactivated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Live Attenuated Polio Vaccine Market Research Report 2024

Global Poultry Killed Vaccines Market Research Report 2025

Global Influenza Vaccine Split Virion Inactivated Quadrivalent Market Research Report 2024

Global Inactivated Poultry Vaccine Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions